Methylene Blue + Photobiomodulation
The published research, summarised.
By Dr. Dorra Frikha-Benayed, PhD · Founder & Scientist, DKGlow · Last reviewed May 21, 2026 · About the author →
One cellular target, two pathways into it.
DKGlow's product line is built on a two-pathway model of mitochondrial wellness: a topical compound that crosses the skin and acts at the electron-transport chain, and a light therapy that reaches tissue depth and stimulates the same chain through a different mechanism. The figure below summarises the model. The rest of this page walks through the published research that informs each pathway and what happens when they're studied together.
Each pathway, separately.
Before talking about the pairing, here's what the published literature says about each compound on its own. Methylene Blue is a synthetic dye with a rich history in medicine; photobiomodulation is a more recently characterised modality with a well-established cellular mechanism.
Methylene Blue in the literature
A synthetic compound first synthesised in 1876 and used clinically since the late 19th century. Its mechanism as a mitochondrial electron carrier is the foundation for nearly all current research interest.
Enhanced cellular energy production
Methylene Blue functions as a mitochondrial electron carrier — facilitating transport along the respiratory chain and supporting ATP production. This mechanism is the foundation for nearly all of MB’s biomedical applications outside its 19th-century origins as a textile dye and antimalarial.
Neuroprotection
MB demonstrates neuroprotective effects in research by inhibiting oxidative stress, modulating neurotransmitter systems, and supporting mitochondrial function. Studied in research contexts including neurodegenerative disease models and traumatic brain injury.
Antimicrobial activity
MB exhibits broad-spectrum antimicrobial activity against bacteria, viruses, and fungi — including strains studied in the context of antibiotic resistance. It is also examined as a photosensitizer in antimicrobial photodynamic-therapy research.
Anti-inflammatory effects
Reduces inflammation in research models by inhibiting pro-inflammatory cytokines and mitigating oxidative stress. Examined across chronic inflammatory and autoimmune research contexts.
Photobiomodulation in the literature
Low-intensity red and near-infrared light delivered to stimulate cellular function. The mechanism most often cited in the literature is absorption by cytochrome c oxidase at red and near-infrared wavelengths.
Cellular energy production
Photobiomodulation research describes light-driven stimulation of ATP production within mitochondria — primarily via absorption by cytochrome c oxidase at specific red and near-infrared wavelengths. Non-invasive; well-established mechanism.
Modulation of inflammatory response
Research reports modulation of inflammatory mediators following exposure to red and near-infrared light — reductions in pro-inflammatory cytokines and increases in anti-inflammatory ones.
Enhanced circulation
Studies describe vasodilation and improved microcirculation, increasing oxygen and nutrient delivery to tissue while supporting clearance of metabolic byproducts.
Tissue repair and regeneration
Photobiomodulation stimulates collagen synthesis and fibroblast activity in research — relevant to skin-quality, wound-healing, and recovery literatures, including scar-formation outcomes in controlled study designs.
Seven pathways where the pair is studied together.
When MB and photobiomodulation are studied as a pair, the literature consistently describes additive effects across these seven research areas. Each entry references a research context — not a product indication.
Supercharged mitochondrial function
Methylene Blue feeds electrons directly into the respiratory chain while photobiomodulation stimulates ATP production via cytochrome c oxidase. Two complementary routes to the same outcome — described in the mitochondrial-energy literature as additive at the cellular level.
Neuroprotection + neuroregeneration
MB's neuroprotective profile is studied alongside the neuroregenerative effects reported for red-light therapy. Research contexts include traumatic brain injury, stroke models, and neurodegenerative disease models such as Alzheimer’s and Parkinson’s.
Antimicrobial synergy
MB's antimicrobial activity is examined alongside infrared's immune-modulating effects in the broader literature on host response to infection. The pairing is of particular interest in research on resistant strains.
Amplified anti-inflammatory pathways
Both modalities reduce inflammation through distinct, complementary pathways — MB via cytokine inhibition and oxidative-stress mitigation, infrared via promotion of anti-inflammatory mediators. The literature treats these as additive, not redundant.
Accelerated healing and recovery research
Studies describe accelerated tissue repair and regeneration when the two modalities are paired. Explored in post-exercise recovery, injury rehabilitation, and chronic-pain research contexts.
Internal + external coverage
A recurring framing in integrative-medicine research: MB acts at the cellular/internal level while photobiomodulation reaches tissue depths of 5–10 mm — the two together span more biological territory than either alone.
Skin-aging research
Research on MB's mitochondrial support and infrared's collagen-related effects describes outcomes relevant to visible-aging research — oxidative stress, dermal elasticity, fibroblast vitality. The Xiong et al. 2021 fibroblast-lifespan study is a foundational reference here.
The pairing's active research frontiers.
These are the directions where the published literature on MB and photobiomodulation is actively expanding. They describe research contexts in the academic literature — not product indications. DKGlow products are personal-care wellness items; the disclaimer at the bottom of this page expands on the distinction.
Neurological research
Research on methylene blue's interaction with mitochondrial function in models of Alzheimer's disease, Parkinson's disease, traumatic brain injury, and neuropathic pain. MB's history as one of the few mitochondrially active small molecules has made it a recurring subject in this literature.
Antimicrobial research
Studies of methylene blue's antimicrobial activity against bacteria, viruses, and fungi — including investigations of strains resistant to conventional antibiotics, and MB's role as a photosensitizer in antimicrobial photodynamic therapy.
Inflammatory and autoimmune research
Photobiomodulation research in chronic-inflammatory and autoimmune contexts — including arthritis, inflammatory bowel disease, and autoimmune-disorder models. Cytokine modulation is the most commonly studied mechanism.
Tissue and skin renewal research
Photobiomodulation studies on tissue renewal and recovery — including the broader skin-renewal literature, post-procedure outcomes, and scar-formation research. The Avci et al. 2013 review remains a foundational reference here.
Selected citations
Methylene Blue — fibroblast lifespan
Xiong et al. (2021). "Anti-Aging Potentials of Methylene Blue for Human Skin Longevity." Scientific Reports.
Read source →Photobiomodulation — clinical efficacy review
Hamblin, M.R. (2016). "Mechanisms and applications of the anti-inflammatory effects of photobiomodulation." AIMS Biophysics.
Read source →Methylene Blue — cellular antioxidant + neuroprotection
Tucker, D., Lu, Y., & Zhang, Q. (2018). "From Mitochondrial Function to Neuroprotection — an Emerging Role for Methylene Blue." Molecular Neurobiology.
Read source →Red light therapy — collagen synthesis
Avci, P. et al. (2013). "Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoring." Seminars in Cutaneous Medicine and Surgery.
Read source →Methylene Blue — skeletal aging (negative in-vivo result)
Poudel, S.B., Frikha-Benayed, D., et al. (2024). "Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging." Aging (Albany NY).
Read source →Osteocyte mitochondrial heterogeneity
Frikha-Benayed, D., et al. (2016). "Regional differences in oxidative metabolism and mitochondrial activity among cortical bone osteocytes." Bone.
Read source →
Dr. Frikha-Benayed's full publication list is available on Google Scholar.
More from Dr. Frikha-Benayed.
Read about Dr. Frikha-Benayed's research background, peer-reviewed publications, and the founding story behind DKGlow.